SCHEMBL2512573

SCHEMBL2512573

CCCCN1Cc2cc(OCc3cnccc3OC)ccc2C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 2/20 0.39
PRMT5 O14744 2/20 0.39
WDR77 Q9BQA1 2/20 0.39
CNR2 P34972 2/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
S1PR1 P21453 1/20 0.37
AXL P30530 1/20 0.37
TNF P01375 1/20 0.37
DRD2 P14416 3/20 0.37
DRD3 P35462 3/20 0.37
DRD5 P21918 1/20 0.37
HTR7 P34969 1/20 0.37
DRD4 P21917 2/20 0.36
EGFR P00533 1/20 0.36
GRM5 P41594 1/20 0.36
PRF1 P14222 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2512685 0.94 ADAM17 (0.40) ADAM17PRMT5WDR77ALDH1A1ITGB3
SCHEMBL2509656 0.83 PRMT5 (0.41) ADAM17PRMT5WDR77ITGB3ITGA2B
SCHEMBL2509809 0.82 PRMT5 (0.40) ADAM17PRMT5WDR77ALDH1A1ITGB3
SCHEMBL2510033 0.79 EGFR (0.43) ADAM17PRMT5WDR77ITGB3ITGA2B
SCHEMBL2507478 0.75 ITGB3 (0.44) ADAM17ALDH1A1LMNAITGB3DRD2
SCHEMBL3640741 0.74 ADAM17 (0.41) ADAM17ALDH1A1LMNAITGB3ITGA2B
SCHEMBL2511076 0.73 PRMT5 (0.37) ADAM17PRMT5WDR77CNR2ITGB3
SCHEMBL2512141 0.73 ITGB3 (0.37) ADAM17PRMT5WDR77ALDH1A1ITGB3
SCHEMBL2511394 0.73 KDM4C (0.38) ALDH1A1ITGB3AXLDRD2DRD3
SCHEMBL3639261 0.72 PRF1 (0.41) ADAM17ITGB3ITGA2BDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US claimed
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US disclosed
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I ABBOTT GMBH & CO. KG (DE) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I GRM3, GRIN2C, GRIN2B ADAM17 4739/4885PRMT5 1226/4885WDR77 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.